First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Stock Price Down 0% – Here’s What Happened

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)’s stock price was down 0% during mid-day trading on Tuesday . The stock traded as low as $34.57 and last traded at $34.57. Approximately 2,081 shares changed hands during mid-day trading, a decline of 74% from the average daily volume of 8,021 shares. The stock had previously closed at $34.58.

First Trust Nasdaq Pharmaceuticals ETF Stock Down 1.6%

The firm has a market cap of $23.74 million, a P/E ratio of 14.51 and a beta of 0.54. The business has a fifty day moving average of $34.32 and a 200 day moving average of $31.69.

Institutional Trading of First Trust Nasdaq Pharmaceuticals ETF

Hedge funds have recently modified their holdings of the company. Bank of Montreal Can increased its stake in First Trust Nasdaq Pharmaceuticals ETF by 68.2% in the second quarter. Bank of Montreal Can now owns 8,221 shares of the company’s stock valued at $211,000 after purchasing an additional 3,333 shares in the last quarter. Envestnet Asset Management Inc. boosted its position in shares of First Trust Nasdaq Pharmaceuticals ETF by 2.1% during the third quarter. Envestnet Asset Management Inc. now owns 18,132 shares of the company’s stock worth $517,000 after purchasing an additional 367 shares in the last quarter. OLD Mission Capital LLC bought a new position in shares of First Trust Nasdaq Pharmaceuticals ETF during the fourth quarter worth $528,000. Goldman Sachs Group Inc. grew its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 11.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 19,472 shares of the company’s stock valued at $535,000 after buying an additional 2,047 shares during the period. Finally, LPL Financial LLC grew its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 40.5% in the 4th quarter. LPL Financial LLC now owns 146,105 shares of the company’s stock valued at $4,813,000 after buying an additional 42,147 shares during the period.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.